FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox 19 May 2022 The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years…
